PATH vs SBRA · P/E 19, rev $1.61B vs P/E 29, rev $774.6M
Uipath Inc (PATH) versus Sabra Healthcare REIT Inc (SBRA) — a side-by-side from cached financials, not a winner call.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Sabra Healthcare REIT Inc (SBRA) is a reit - healthcare facilities company listed on NASDAQ.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Latest reported SBRA revenue for 2025-12-31 was $774.6M. Net income was $155.6M. Revenue was up 10.2% from 2024-12-31 to 2025-12-31. SBRA currently screens at market cap $4.55B and trailing P/E 28.7.
PATH currently screens at market cap $6.07B and trailing P/E 19.4. SBRA currently screens at market cap $4.55B and trailing P/E 28.7.
Not investment advice. Open the PATH and SBRA stock pages for the full models.
Not investment advice.